✦ LIBER ✦

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)

✍ Scribed by Gaidzik, V. I.; Schlenk, R. F.; Paschka, P.; Stolzle, A.; Spath, D.; Kuendgen, A.; von Lilienfeld-Toal, M.; Brugger, W.; Derigs, H. G.; Kremers, S.; Greil, R.; Raghavachar, A.; Ringhoffer, M.; Salih, H. R.; Wattad, M.; Kirchen, H. G.; Runde, V.; Heil, G.; Petzer, A. L.; Girschikofsky, M.; Heuser, M.; Kayser, S.; Goehring, G.; Teleanu, M.-V.; Schlegelberger, B.; Ganser, A.; Krauter, J.; Bullinger, L.; Dohner, H.; Dohner, K.

Book ID: 121346163
Publisher: American Society of Hematology
Year: 2013
Tongue: English
Weight: 1007 KB
Volume: 121
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2012-10-461624

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TET2 Mutations in Acute Myeloid Leukemia

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group

✍ Gaidzik, V. I.; Paschka, P.; Spath, D.; Habdank, M.; Kohne, C.-H.; Germing, U.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 220 KB

Prognostic impact of DNMT3A mutations in

Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia

✍ Jana Marková; Petra Michková; Kateřina Burčková; Jana Březinová; Kyra Michalová; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Age-Related Prognostic Impact of Differe

✍ Marcucci, G.; Metzeler, K. H.; Schwind, S.; Becker, H.; Maharry, K.; Mrozek, K.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 175 KB

Prognostic Significance of CEBPA Mutatio

Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations

✍ Green, C. L.; Koo, K. K.; Hills, R. K.; Burnett, A. K.; Linch, D. C.; Gale, R. E 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 233 KB

No nucleophosmin mutations in pediatric

No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group

✍ Shimada, A; Taki, T; Kubota, C; Tawa, A; Horibe, K; Tsuchida, M; Hanada, R; Tsuk 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Significance of age in acute myeloid leu

Significance of age in acute myeloid leukemia patients younger than 30 years : A common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A

✍ Ursula Creutzig; Thomas Büchner; Maria C. Sauerland; Martin Zimmermann; Dirk Rei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

## Abstract ## BACKGROUND. Data on the impact of age in acute myeloid leukemia (AML) patients <30 years treated in pediatric and adult trials are scarce. ## METHODS. In all, 891 patients <18 years were treated in the pediatric trials AML‐BFM 93/98 and 290 adolescents and young adults (>16 to <30